Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Just Released: "Dental Caries - Pipeline Review, H2 2013"


Print article Print article
2013-12-20 11:39:24 - New Pharmaceuticals market report from Global Markets Direct: "Dental Caries - Pipeline Review, H2 2013"

Global Markets Direct's, 'Dental Caries - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Dental Caries, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dental Caries. Dental Caries - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated

disease.

Scope

* A snapshot of the global therapeutic scenario for Dental Caries.
* A review of the Dental Caries products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Dental Caries pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Full Report Details at
- www.fastmr.com/prod/755167_dental_caries_pipeline_review_h2_2013 ..

Reasons to Get this Report

* Identify and understand important and diverse types of therapeutics under development for Dental Caries.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Dental Caries pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Companies Mentioned in this Report: Aphios Corporation, Oragenics, Inc., C3 Jian, Inc, Canopus BioPharma Incorporated, Ensoltek Co., Ltd.

Report Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Dental Caries Overview
Therapeutics Development
An Overview of Pipeline Products for Dental Caries
Dental Caries Therapeutics under Development by Companies
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Dental Caries Therapeutics - Products under Development by Companies
Companies Involved in Dental Caries Therapeutics Development
Aphios Corporation
Oragenics, Inc.
C3 Jian, Inc
Canopus BioPharma Incorporated
Ensoltek Co., Ltd.
Dental Caries - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
SMaRT Replacement Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Asterias - Drug Profile
Product Description
Mechanism of Action
R&D Progress
C-16G2 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Carolacton - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Sharon-2000 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Dental Caries Therapeutics - Drug Profile Updates
Dental Caries Therapeutics - Dormant Products
Dental Caries - Product Development Milestones
Featured News & Press Releases
Feb 19, 2013: C3 Jian Completes C16G2 Phase I Clinical Study Enrollment
May 24, 2012: C3 Jian Obtains FDA Acceptance Of Investigational New Drug Application
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Dental Caries, H2 2013
Products under Development for Dental Caries - Comparative Analysis, H2 2013
Number of Products under Development by Companies, H2 2013
Comparative Analysis by Early Clinical Stage Development, H2 2013
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H2 2013
Products under Development by Companies, H2 2013
Aphios Corporation, H2 2013
Oragenics, Inc., H2 2013
C3 Jian, Inc, H2 2013
Canopus BioPharma Incorporated, H2 2013
Ensoltek Co., Ltd., H2 2013
Assessment by Monotherapy Products, H2 2013
Assessment by Stage and Route of Administration, H2 2013
Assessment by Stage and Molecule Type, H2 2013
Dental Caries Therapeutics - Drug Profile Updates
Dental Caries Therapeutics - Dormant Products

List of Figures
Number of Products under Development for Dental Caries, H2 2013
Products under Development for Dental Caries - Comparative Analysis, H2 2013
Products under Development by Companies, H2 2013
Early Clinical Stage Products, H2 2013
Discovery and Pre-Clinical Stage Products, H2 2013
Assessment by Monotherapy Products, H2 2013
Assessment by Route of Administration, H2 2013
Assessment by Stage and Route of Administration, H2 2013
Assessment by Molecule Type, H2 2013
Assessment by Stage and Molecule Type, H2 2013

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com